Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Change in Acquisitions & Divestments (2021 - 2023)

Invivyd's (IVVD) quarterly Change in Acquisitions & Divestments came in at $77.9 million in Q4 2023, up 289.59% on a YoY basis from $20.0 million in Q4 2022, and down 18.1% quarter-over-quarter from $95.1 million in Q3 2023.

Analysis

Invivyd (IVVD) Change in Acquisitions & Divestments (2021 - 2023) Analysis & Trends

Invivyd (IVVD) has reported Change in Acquisitions & Divestments for 3 consecutive years, with $77.9 million the latest figure, recorded in Q4 2023.

  • For the quarter ending Q4 2023, Change in Acquisitions & Divestments rose 289.59% year-over-year to $77.9 million; the trailing twelve-month figure through Sep 2024 stood at $77.9 million (down 75.23% YoY), and the FY2023 full-year result was $372.5 million, up 439.86% from the prior year.
  • Change in Acquisitions & Divestments fell to $77.9 million in Q4 2023 per IVVD's latest filing, from $95.1 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $138.0 million in Q4 2021 and bottomed at $20.0 million in Q4 2022.
  • Historically, Change in Acquisitions & Divestments has averaged $82.8 million across 3 years, with a median of $77.9 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments plunged 85.51% in 2022, then soared 289.59% in 2023.
  • Over 3 years, Change in Acquisitions & Divestments stood at $138.0 million in 2021, then slumped by 85.51% to $20.0 million in 2022, then jumped by 289.59% to $77.9 million in 2023.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $77.9 million, $95.1 million, and $123.8 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 77.92 Mn
Sep 30, 2023 95.14 Mn
Jun 30, 2023 123.79 Mn
Mar 31, 2023 75.66 Mn
Dec 31, 2022 20.00 Mn
Mar 31, 2022 49.00 Mn
Dec 31, 2021 138.00 Mn